Literature DB >> 28120182

Expression of YAP1 in aggressive thyroid cancer.

Marilena Celano1, Chiara Mignogna1, Francesca Rosignolo2, Marialuisa Sponziello2, Michelangelo Iannone3, Saverio Massimo Lepore1, Giovanni Enrico Lombardo1, Valentina Maggisano1, Antonella Verrienti2, Stefania Bulotta1, Cosimo Durante2, Carla Di Loreto4, Giuseppe Damante4, Diego Russo5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28120182     DOI： 10.1007/s12020-017-1240-6

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  17 in total

Review 1.  Thyroid cancer.

Authors:  Maria E Cabanillas; David G McFadden; Cosimo Durante
Journal:  Lancet       Date:  2016-05-27       Impact factor: 79.321

Review 2.  Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.

Authors:  Stefania Bulotta; Marilena Celano; Giuseppe Costante; Diego Russo
Journal:  Endocrine       Date:  2015-12-21       Impact factor: 3.633

3.  NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.

Authors:  Maria E R Garcia-Rendueles; Julio C Ricarte-Filho; Brian R Untch; Iňigo Landa; Jeffrey A Knauf; Francesca Voza; Vicki E Smith; Ian Ganly; Barry S Taylor; Yogindra Persaud; Gisele Oler; Yuqiang Fang; Suresh C Jhanwar; Agnes Viale; Adriana Heguy; Kety H Huberman; Filippo Giancotti; Ronald Ghossein; James A Fagin
Journal:  Cancer Discov       Date:  2015-09-10       Impact factor: 39.397

4.  PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells.

Authors:  Marialuisa Sponziello; Antonella Verrienti; Francesca Rosignolo; Roberta Francesca De Rose; Valeria Pecce; Valentina Maggisano; Cosimo Durante; Stefania Bulotta; Giuseppe Damante; Laura Giacomelli; Cira Rosaria Tiziana Di Gioia; Sebastiano Filetti; Diego Russo; Marilena Celano
Journal:  Endocrine       Date:  2015-04-03       Impact factor: 3.633

Review 5.  YAP/TAZ for cancer therapy: opportunities and challenges (review).

Authors:  Liwen Guo; Lisong Teng
Journal:  Int J Oncol       Date:  2015-02-05       Impact factor: 5.650

6.  Role of YAP-1 in Thyroid Tumor Progression and Outcome.

Authors:  Clara Ugolini; Nicla Borrelli; Cristina Niccoli; Rossella Elisei; David Viola; Paolo Vitti; Paolo Miccoli; Fulvio Basolo
Journal:  Appl Immunohistochem Mol Morphol       Date:  2017-09

7.  Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours.

Authors:  Marialuisa Sponziello; Cosimo Durante; Amelie Boichard; Mariavittoria Dima; Cinzia Puppin; Antonella Verrienti; Giulia Tamburrano; Giorgio Di Rocco; Adriano Redler; Ludovic Lacroix; Jean-Michel Bidart; Martin Schlumberger; Giuseppe Damante; Diego Russo; Sebastiano Filetti
Journal:  Mol Cell Endocrinol       Date:  2014-05-09       Impact factor: 4.102

Review 8.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

9.  RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer.

Authors:  S E Lee; J U Lee; M H Lee; M J Ryu; S J Kim; Y K Kim; M J Choi; K S Kim; J M Kim; J W Kim; Y W Koh; D-S Lim; Y S Jo; M Shong
Journal:  Oncogenesis       Date:  2013-07-15       Impact factor: 7.485

10.  Role of Yes-associated protein in cancer: An update.

Authors:  Ramazan Abylkassov; Yingqiu Xie
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967
View more
  6 in total

1.  Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.

Authors:  Valentina Maggisano; Marilena Celano; Saverio Massimo Lepore; Marialuisa Sponziello; Francesca Rosignolo; Valeria Pecce; Antonella Verrienti; Federica Baldan; Catia Mio; Lorenzo Allegri; Marianna Maranghi; Rosa Falcone; Giuseppe Damante; Diego Russo; Stefania Bulotta
Journal:  Endocrine       Date:  2019-01-19       Impact factor: 3.633

2.  Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells.

Authors:  Marilena Celano; Valentina Maggisano; Saverio Massimo Lepore; Marialuisa Sponziello; Valeria Pecce; Antonella Verrienti; Cosimo Durante; Marianna Maranghi; Piernatale Lucia; Stefania Bulotta; Giuseppe Damante; Diego Russo
Journal:  Int J Endocrinol       Date:  2019-02-14       Impact factor: 3.257

3.  Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1.

Authors:  Weifeng Zhong; Zhiming Wu; Nanhui Chen; Kaihua Zhong; Yifeng Lin; Huiming Jiang; Pei Wan; Shanming Lu; Lawei Yang; Siping Liu
Journal:  Biomed Res Int       Date:  2019-04-24       Impact factor: 3.411

4.  The LINC01186 suppresses cell proliferation and invasion ability in papillary thyroid carcinoma.

Authors:  Nanpeng Wang; Haisong Duan; Chen Zhang; Yan Zhou; Rongjun Gao
Journal:  Oncol Lett       Date:  2018-08-22       Impact factor: 2.967

5.  Nanoparticles Loaded with the BET Inhibitor JQ1 Block the Growth of Triple Negative Breast Cancer Cells In Vitro and In Vivo.

Authors:  Valentina Maggisano; Marilena Celano; Rocco Malivindi; Ines Barone; Donato Cosco; Catia Mio; Chiara Mignogna; Salvatore Panza; Giuseppe Damante; Massimo Fresta; Sebastiano Andò; Diego Russo; Stefania Catalano; Stefania Bulotta
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639

6.  The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.

Authors:  Yong Huang; KeWei Zhang; Yinghua Li; Yuyin Dai; Hongguang Zhao
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.